Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Pyxis Oncology Inc (NASDAQ: PYXS) closed at $2.01 in the last session, up 9.84% from day before closing price of $1.83. In other words, the price has increased by $9.84 from its previous closing price. On the day, 2.47 million shares were traded. PYXS stock price reached its highest trading level at $2.13 during the session, while it also had its lowest trading level at $1.97.
Ratios:
We take a closer look at PYXS’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.33 and its Current Ratio is at 7.33. In the meantime, Its Debt-to-Equity ratio is 0.13 whereas as Long-Term Debt/Eq ratio is at 0.12.
On November 08, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $13.
On August 08, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $10.Stifel initiated its Buy rating on August 08, 2024, with a $10 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 26 ’24 when Connealy Pamela Ann bought 88,850 shares for $1.96 per share. The transaction valued at 174,364 led to the insider holds 1,199,143 shares of the business.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PYXS now has a Market Capitalization of 119526056 and an Enterprise Value of -4751884. For the stock, the TTM Price-to-Sale (P/S) ratio is 8.13 while its Price-to-Book (P/B) ratio in mrq is 0.78. Its current Enterprise Value per Revenue stands at -0.294 whereas that against EBITDA is 0.078.
Stock Price History:
Over the past 52 weeks, PYXS has reached a high of $6.85, while it has fallen to a 52-week low of $1.48. The 50-Day Moving Average of the stock is -42.60%, while the 200-Day Moving Average is calculated to be -49.57%.
Shares Statistics:
According to the various share statistics, PYXS traded on average about 1.04M shares per day over the past 3-months and 3608590 shares per day over the past 10 days. A total of 44.75M shares are outstanding, with a floating share count of 41.12M. Insiders hold about 25.98% of the company’s shares, while institutions hold 51.86% stake in the company. Shares short for PYXS as of 1731628800 were 5841190 with a Short Ratio of 5.64, compared to 1728950400 on 4909364. Therefore, it implies a Short% of Shares Outstanding of 5841190 and a Short% of Float of 11.93.
